Licensing Strategies: Benchmarking Analysis of the Top 20 Pharmaceutical Companies - Market Research Reports

Welcome - Home - Register - Login - Help/FAQ - 0 items

Search
Enter keywords, a title or
a report id number below.

Advanced


	Select a currency for use throughout the site

Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying

| More

Hard Copy
Electronic
CD ROM

Licensing Strategies: Benchmarking Analysis of the Top 20 Pharmaceutical Companies
Datamonitor, May 2003, Pages: 177



		Description



		Table of Contents



		Enquire before Buying


	Send to a Friend

Send to a Friend

To email a friend details of Licensing Strategies: Benchmarking Analysis of the Top 20 Pharmaceutical Companies complete the form below and click on "Send".

* Required Information

Your Friend's Details

Friend's Full Name *

Friend's Email Address *

A message for your Friend

Your Contact Details

Your Name *

Email Address *

Customers who bought this item also bought

Licensing Strategies - Examining Today’s Pharmaceutical Licensing Trends

Guide to Valuation of Pharmaceutical Licensing Deals

Evolving Trends in Biopharmaceutical Licensing: Deal Assessments, Drivers and Resistors

Licensing Strategies: Trends In The Top 20 Pharmaceutical Companies Activity

Valuing and Structuring Pharmaceutical Licensing Agreements

Bio-Device Licensing: Strategies for Success

Pharmaceutical Licensing Strategies: Best Practices in Deal-Making, Valuations and Strategic Management

Evolving Trends in Licensing: Strategies for Building and Retaining Value in Biotechnology Alliances

The Pharmaceutical Licensing Outlook: A Strategic Guide To Effective Deal-Making And Profitable Partnerships

Licensing Strategies for Accessing Biomarker Technologies

Licensing in Antibacterial R&D - Filling the Gaps

Biotechnology Licensing: How Has the Balance of Power Shifted?

Top of page